Banner MD Anderson Cancer Center at Banner Gateway Medical Center

Gilbert, AZ
Website
(888) 803-1766

Sorting 2 by

Accepting patients

APG-115

A Phase Ib/II Study of APG-115 Alone or in Combination With Azacitidine in Patients With Relapse/Refractory AML, CMML or MDS
Learn more
  • MDM2 Inhibitor
  • Phase 1/2

Not yet accepting

Lisaftoclax

A Global Multicenter, Double-blind, Randomized, Registrational Phase 3 Study of Lisaftoclax (APG-2575) in Combination With Azacitidine (AZA) in Patients With Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS) (GLORA-4).
Learn more
  • BCL-2 Inhibitor
  • Placebo
  • Randomization
  • Phase 3
Get personalized results in 60 seconds
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials